Analysis Achilles Therapeutics plc (ACHL)
6/3/2024
Analysis of Achilles Therapeutics plc (ACHL)
Achilles Therapeutics plc (ACHL) has shown some volatility in its stock price over the past few days. The stock closed at $0.94, slightly lower than the previous day's close of $0.92. The Relative Strength Index (RSI) is around 55.6, indicating a neutral sentiment in the market.Looking at the Moving Average Convergence Divergence (MACD) indicator, the MACD line is above the signal line, with a positive MACD histogram, suggesting a bullish momentum in the stock price.
In terms of moving averages, the Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) are all showing an upward trend, indicating a positive outlook for the stock.
Overall, based on the technical indicators, Achilles Therapeutics plc seems to be in a consolidation phase with a slightly bullish bias. Traders and investors may want to monitor the stock closely for potential trading opportunities.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is 5.2%.
3. Current Year: The estimated growth rate for the current year is 7.6%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 9.7%.
These estimates suggest a positive growth trend for the company, with a slight slowdown compared to the past 5 years but still showing healthy growth prospects in the near future.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
- Currency: USD
Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security, with a median forecast of $201.43 and an average forecast of $204.58. However, it's worth noting that there is a wide range of forecasts, from a low of $164 to a high of $275. The current price of the security is $192.25, which is below both the median and average forecasted prices.
Earnings
The company's results for the most recent quarter ending on April 30, 2025, have not been provided at this time. The previous results were reported on February 27, 2025, through the Transfer Agent. Before that, on January 31, 2025, the results were released after hours. The results for October 31, 2024, were not provided at the time. On August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.Financials:
- Cash flow: Operating cash flow TTM is $110,563,000,320 and levered free cash flow TTM is $84,726,874,112.
- Balance sheet: Total cash MRQ is $67,150,000,128, total debt MRQ is $104,590,000,128, current ratio MRQ is 1.037, book value per share MRQ is $4.837, total cash per share MRQ is $4.379, and total debt to equity MRQ is 140.968.
- Profit margin is 26.306%.
- Fiscal year ends on September 30, 2023.
- Income statement: EBITDA is $131,393,000,000, revenue TTM is $381,623,009,280, diluted EPS TTM is $6.43, gross profit TTM is $169,148,000,000, revenue per share TTM is $24.537, net income to common TTM is $100,389,003,264, quarterly revenue growth is -4.3%, and quarterly earnings growth YoY is -2.2%.
- Operating margin is 30.743%.
- Return on assets TTM is 22.073999% and return on equity TTM is 147.25%.
- Most recent quarter is March 31, 2024.
Stock statistics:
- Short ratio is 1.53.
- Float shares are 15,308,320,742.
- Shares short are 99,287,450.
- Average 10-day volume is 46,860,048.
- Average 90-day volume is 57,498,254.
- Shares outstanding are 15,334,099,968.
- Percent held by insiders is 5.22% and percent held by institutions is 57.589%.
- Short percent of shares outstanding is 0.65%.
Valuation metrics:
- PEG ratio is 26.319502.
- Forward PE is 26.319502.
- Trailing PE is 29.59409.
- Enterprise value is $2,950,762,332,160.
- Price to book MRQ is 39.3405.
- Price to sales TTM is 7.646095.
- Enterprise to EBITDA is 22.763.
- Enterprise to revenue is 7.732.
- Market capitalization is $2,917,925,650,432.
Stock price summary:
- Beta is 1.264.
- 50-day moving average is $176.2646.
- 200-day moving average is $181.0429.
- Fifty-two week low is $164.08.
- Fifty-two week high is $199.62.
- Fifty-two week change is 6.853%.
Dividends and splits:
- Payout ratio is 14.93%.
- Dividend date is May 16, 2024.
- Last split date is August 31, 2020.
- Ex-dividend date is May 10, 2024.
- Last split factor is a 4-for-1 split.
- Forward annual dividend rate is $1.
- 5-year average dividend yield is 0.73%.
- Forward annual dividend yield is 0.5255%.
- Trailing annual dividend rate is $0.97.
- Trailing annual dividend yield is 0.5097%.
Income statement 💸
These are the revenues. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the past four fiscal years.
2. The gross profit margin seems to be consistent, indicating efficient cost management.
3. Earnings before interest and taxes (EBIT) have also shown a positive trend, reflecting the company's operational efficiency.
4. Net income has been growing, suggesting that the company is effectively managing its expenses and taxes.
5. The basic and diluted earnings per share (EPS) have been relatively stable over the years.
6. The company has been able to maintain a healthy operating income despite fluctuations in non-operating interests and expenses.
7. Overall, the financial performance of the company seems to be strong and improving over the years.
Balance Sheet
These are balance sheets. Here are the conclusions based on the provided data:1. The total assets have been increasing over the years, reaching the highest value in 2023 at $352,755,000,000.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2023 at $217,350,000,000.
4. Total liabilities have also been increasing, reaching the highest value in 2023 at $302,083,000,000.
5. Shareholders' equity has been fluctuating, with the highest value in 2019 at $90,488,000,000.
6. The company seems to be investing more in non-current assets over the years, which might indicate long-term growth strategies.
7. The increase in total liabilities suggests that the company is relying more on external funding sources.
8. The fluctuations in shareholders' equity indicate changes in the company's retained earnings and investments.
9. Overall, the company's financial position seems to be stable, with a focus on long-term growth and investment.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchases and debt issuances/payments, with significant amounts involved.
6. Investing activities reflect the company's involvement in acquisitions, investments, and capital expenditures, with varying levels of cash flow.
7. Overall, the company's financial activities show a mix of strategies to manage cash flow, invest in growth, and return value to shareholders.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share (EPS), we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This represents an increase from the EPS of $1.17 reported a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is higher at $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This is also an improvement from the EPS of $1.35 from the same quarter last year.
3. Looking at the estimates for the current fiscal year ending on September 30, 2024, analysts project an average EPS of $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This shows growth compared to the EPS of $5.67 in the previous fiscal year.
4. For the next fiscal year ending on September 30, 2025, analysts anticipate a further increase in EPS to an average of $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This is an improvement from the EPS of $6.10 in the current fiscal year.
Overall, the analysts' estimates suggest a positive outlook for the company's earnings per share, indicating growth in both the short term and the long term.
MACD of ACHL
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
